Calcium, when interacting with phosphate, can trigger severe inflammatory reactions in patients with rheumatic diseases. “The pro-inflammatory effect of calcium ions had previously been studied in relation to chronic bronchitis and obesity; evidence of this in rheumatic diseases is entirely new. ‘This discovery now makes it possible to develop new therapeutic approaches for rheumatic and chronic inflammatory diseases,’ explains Prof. Dr Ulf Wagner of Leipzig University Hospital.
Phosphate also plays an important role alongside calcium. At elevated concentrations of these ions, calcium-phosphate nanoparticles form, which can trigger massive inflammatory reactions in immune cells. In rheumatoid arthritis (RA), these nanoparticles, in combination with calcium ions, lead to a significantly stronger inflammatory response than in healthy individuals. This is accompanied by the production of potent signalling molecules. These play a key role in rheumatic diseases. Blocking them with medication is the most effective form of treatment for RA.
The uptake of calcium-phosphate nanoparticles, triggered by calcium ions, can lead to joint inflammation in rheumatic conditions. However, the driving force is always an elevated calcium concentration in the vicinity of inflamed joints, whilst calcium uptake or the systemic regulation of calcium levels does not appear to play a role. The release of calcium and phosphate from the bone that occurs in this condition, as a result of bone decalcification or destruction, may contribute to the disease becoming chronic.
References:
Leipzig University Hospital, University of Leipzig https://www.uni-leipzig.de/newsdetail/artikel/verbindung-aus-calcium-und-phosphat-loest-starke-entzuendung-bei-rheumapatienten-aus-2020-09-10/
Calcium-sensing receptor-mediated NLRP3 inflammasome response to calciprotein particles drives inflammation in rheumatoid arthritis. Nature Communications, https://doi.org/10.1038/s41467-020-17749-6